Not checked for notices yet.
Current and future landscape of targeted therapy in HER2-positive advanced breast cancer: redrawing the lines
Christine Simmons, Daniel Rayson, Anil Abraham Joy and 6 more
Therapeutic Advances in Medical Oncology · 2022
Cited by papers we hold 1
- Emerging Targeted Therapies for HER2-Positive Breast Cancer · 2023No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.